BEONE MEDICINES LTD. Equity Method Investment, Other than Temporary Impairment
BEONE MEDICINES LTD. (ONC) reported Equity Method Investment, Other than Temporary Impairment of $40.38 million for the 3-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2026-02-26
- BEONE MEDICINES LTD. equity method investment, other than temporary impairment for the quarter ending 2025-12-31 was $40.38M.
- BEONE MEDICINES LTD. equity method investment, other than temporary impairment for fiscal 2024 was $7.63M, a 1.41% increase from fiscal 2023.
- BEONE MEDICINES LTD. equity method investment, other than temporary impairment for fiscal 2023 was $7.53M.
- BEONE MEDICINES LTD. equity method investment, other than temporary impairment for fiscal 2022 was $0.00.
- BEONE MEDICINES LTD. equity method investment, other than temporary impairment for fiscal 2021 was $0.00.
| Period end | Equity Method Investment, Other than Temporary Impairment 3 month | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|---|
| 2025-12-31 | $40.38M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $7.63M 10-K · filed 2025-02-27 | |
| 2023-12-31 | $7.53M 10-K · filed 2025-02-27 | |
| 2022-12-31 | $0.00 10-K · filed 2024-02-26 | |
| 2021-12-31 | $0.00 10-K · filed 2024-02-26 |